Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698789 · ClinicalTrials.gov registry record · Phase 2
Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes
A Phase 2 study, sponsored by Incyte Corporation.
- Terminated
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT00698789 is a Phase 2 study that was terminated before completion, run by Incyte Corporation. The registered enrollment target is 48 participants.
The verdict
NCT00698789, a Phase 2 study, was terminated before completion, sponsored by Incyte Corporation.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
Determine the effect of treatment with INCB019602 administered as an add-on to stable dose metformin therapy in type 2 diabetic subjects on safety and glycemic control.
Interventions
- DRUG INCB019602
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00698789
The ClinicalTrials.gov registry entry for NCT00698789 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Incyte Corporation, which has 239 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INCB019602 is the first listed.
NCT00698789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00698789 about?
NCT00698789 is a clinical study titled "Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes". Determine the effect of treatment with INCB019602 administered as an add-on to stable dose metformin therapy in type 2 diabetic subjects on safety and glycemic control.
What is the current status of trial NCT00698789?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2008-05. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00698789?
The interventions under investigation include: INCB019602 (DRUG).
Who is sponsoring clinical trial NCT00698789?
This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.